Inside the NIH’s controversial decision to stop its big remdesivir study

A clinical trial for remdesivir, Gilead's Covid-19 treatment, faced one of the toughest quandaries in medicine: how to balance the need to rigorously test the medicine with the imperative to…

Click to view original post